ALKS News and Press, Alkermes plc From 03/19/24

2024-03-19 14:37:43 ET More on Alkermes Alkermes plc 2023 Q4 - Results - Earnings Call Presentation Alkermes plc (ALKS) Q4 2023 Earnings Call Transcript Alkermes: Additional Narcolepsy Data Could Lead The Way To The Next Stage Alkermes downgraded at UBS as st...

2024-03-18 14:07:39 ET Summary The healthcare sector is overvalued by about 13% relative to 11-year averages, but overvaluation varies a lot across subsectors. Healthcare equipment has the worst value and quality scores. iShares Global Healthcare ETF is a global alternative to...

Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors PR Newswire DUBLIN , March 7, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced the appointment of a new independent director, Nancy S. Lurker, to the company's Board of Di...

2024-02-21 13:04:28 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biotech stocks are often at the forefront of innovation. These are the companies we hear about that are driving breakthroughs in healthcare. Essentially, they are responsible for improving ...

2024-02-20 12:32:42 ET More on Alkermes Alkermes: Additional Narcolepsy Data Could Lead The Way To The Next Stage Alkermes to sell Athlone facility in Ireland to Novo Nordisk for $92.5M Alkermes Q4 2023 Earnings Preview Alkermes plc 2023 Q4 - Results - Earnin...

2024-02-18 05:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-02-16 11:10:43 ET More on iShares Russell 2000 ETF: IWM: Technical Analysis Says You Should Buy Small Caps IWM: Supply-Side Disinflation Benefits Small Caps The Most Small-Cap ETFs: Performance, Fundamentals, And Rankings For 102 Funds Investors retract ...

2024-02-15 15:08:12 ET Alkermes plc (ALKS) Q4 2023 Earnings Conference Call February 15, 2024, 08:00 AM ET Company Participants Sandra Coombs - Senior Vice President, Corporate Affairs and Investor Relations Richard Pops - Chairman and Chief Executive Officer Tod...

2024-02-15 07:07:23 ET More on Alkermes Alkermes: Additional Narcolepsy Data Could Lead The Way To The Next Stage Alkermes: Slimmed-Down Pharma Not A Compelling Growth Story Yet Alkermes Q4 2023 Earnings Preview Alkermes to sell Athlone facility in Ireland to...

Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2023 and Provides Financial Expectations for 2024 PR Newswire — Total Revenues of $1.66 Billion in 2023; Net Sales of Proprietary Products Increased Approximately 18% Year-Over-Yea...